On the other hand, the restored YAP/TAZ target gene expression after co-depletion of STRN3 and MAP4K4 also indicated that tumor growth suppression we observed by this treatment in the tissue (Fig. 3a) cannot solely be explained by its impact on YAP/TAZ target gene expression. The gene discussed is MAP4K4; the disease is neoplasm.